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Narcolepsy is a rare hypersomnia of central origin characterized
by hypersomnolence, direct transition from wakefulness to rapid
eye movement (REM) sleep, and other dissociated states of
wake-REM sleep. It is distinguished into narcolepsy type 1
(with cerebrospinal fluid [CSF] hypocretin-1 [hcrt-1] deficiency
and/or with cataplexy) and narcolepsy type 2 (without cataplexy
and normal CSF hcrt-1).1 Narcolepsy is associated with human
leukocyte antigen (HLA) DQB1*0602 allele, and evidence sug-
gests that a T-cell-mediated autoimmune process may destroy
hypothalamic hypocretinergic cells causing narcolepsy.2 Indeed,
streptococcal and H1N1 influenza infections are considered the
strongest candidates as environmental triggers.2 Therefore, nar-
colepsy could also be considered an autoimmune poststrepto-
coccal disease as with some basal ganglia disorders with acute
onset in childhood of motor and behavioral symptoms and epi-
sodic course.3 This case report suggests a common underlying
immune-mediated mechanism for both narcolepsy and tics.
Case Report
A 16-year-old boy previously in good health presented in
November 2012, following a febrile throat infection, with an
acute onset of somnolence, with long-lasting night-sleep period,
remarkable sleep inertia, and nonrestorative, prolonged (up to
hours) daytime-sleep episodes. Facial tics, irritability, and aggres-
siveness were also noted. The patient’s mother had a past his-
tory of tics during adolescence. The rest of the family history
was unremarkable. Although, throughout the ensuing months,
most of the patient’s symptoms spontaneously improved, there
was persistent hypersomnolence and the patient was referred to
our center 10 months later.
Clinical and neurological examinations were normal, except
for facial tics, namely, eye blinking, nose wrinkling, and gri-
macing. Growth and sexual development were in the age aver-
age (see Video). The patient was not aware of his tics, and he
denied any associated preceding urge to perform them. How-
ever, he was able to completely suppress them on demand.
Objective assessments by means of established tic scales yielded
the following results: Yale Global Tic Severity Scale (YGTSS)
score, 8; Rush videotape rating scale score, 5. Serological assays
disclosed elevated anti-streptolysin O (ASO) titers (939 UI/
mL), but were negative for antibasal ganglia and anti–N-
methyl-D-aspartate antibodies. The Obsessive Compulsive
Inventory-Revised questionnaire did not suggest an obsessive-
compulsive disorder (score, 14; normal, <21). Subjective sleepi-
ness was pathological (Epworth Sleepiness Scale [ESS] score: 12;
normal, ≤10). A 7-day actigraphic monitoring showed a
24-hour profile characterized by prolonged nighttime sleep per-
iod, remarkable sleep inertia, and recurring (4/week) prolonged
daytime naps (Fig. 1A). Nighttime polysomnography (PSG) was
unremarkable (total sleep time [TST]: 7 hours and 49 minutes,
sleep latency [SL]: 5 minutes; sleep efficiency [SE]: 95%), but
the multiple sleep latency test (MSLT) showed pathological
mean sleep latency (5 minutes and 53 seconds; pathological,
<8 minutes) with three sleep-onset REM-sleep periods
(SOREMPs) of five sleep opportunities. Brain MRI and CSF
hcrt-1 (33,988 pg/mL) were normal. The patient carried the
HLA DQB1*0602 allele. Accordingly, narcolepsy type 2 was
diagnosed. A treatment with modafinil up to 200 mg daily was
started and immediately withdrawn for insomnia. After a further
9 months, at clinical follow-up, the patient and parents reported
a remarkable global improvement of both tics and hypersomno-
lence (YGTSS score: 5; Rush videotape rating scale score: 3;
ESS score: 4). Actigraphic monitoring confirmed a decrease of
24-hour TST, shorter night-sleep, and fewer (2/week) and
shorter daytime naps (Fig. 1B). The MSLT confirmed hyper-
somnolence disappearance, showing normal mean sleep latency
(9 minutes and 30 seconds) without SOREMPs. PSG disclosed
a normal nighttime sleep (TST, 6 hours and 24 minutes; SL,
10 minutes; SE, 94%), with a reduced total sleep time com-
pared to previous assessment. ASO titer was normalized
(218 UI/mL).
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Discussion
Our case suggests that a central disorder of hypersomnolence
(narcolepsy type 2) and motor disorders (tics) may cluster in
association with streptococcal infection. The parallel waning
course of both phenomena endorses this link. Either for narco-
lepsy, as well as for basal ganglia disorders, an association with
autoimmunity is strongly suspected. High ASO titers are indeed
frequently detected around the onset of narcolepsy4,5 and of Sy-
denham chorea, basal ganglia encephalitis, pediatric autoimmune
neuropsychiatric disorder associated with streptococcal infection
(PANDAS), and tic disorders.3 In many of these disorders,
sleepiness has been seldom reported,6,7 but never systematically
investigated, suggesting that it may have been overlooked. A
link between hypersomnolence and movement disorders has
also been highlighted by the constellation of movement disor-
ders that identify childhood narcolepsy type 1,5 pinpointing the
need of a more systematic and comprehensive evaluation of this
overlap. Narcolepsy and tic disorders also share an impaired
functioning of hypothalamus-hypophysis axis that has been sug-
gested in Tourette syndrome8 and in narcolepsy type 1.9 How-
ever, our patient did not show clinical or brain MRI evidence
of such a wider hypothalamic involvement. Although our
patient did not experience any premonitory sensation, he was
able to suppress his tics when required, highlighting that pre-
monitory urges are indeed not a prerequisite of voluntary tic
inhibition, as previously suggested.10
Finally, although, in this case, we speculate on a common
underlying immune-mediated mechanism for both narcolepsy
and tics, we acknowledge that we cannot exclude a pre-existing
mild tic disorder enhanced by hypersomnolence.
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period reported by the patient. Red underline: sleep time estimated by actigraphic algorhythm analysis. Fuchsia highlight = periods when
the actigraph was not worn by the patient.
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Supporting Information
A video accompanying this article is available in the supporting
information here.
Video. The video shows the characteristics of facial simple
motor tics (eye blinking, nose wrinkling, and grimacing) as the
patient was watching a movie, alone in the examination room.
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